Page 22 - Read Online
P. 22

Tokuyasu et al. J Cancer Metastasis Treat 2018;4:2  I  http://dx.doi.org/10.20517/2394-4722.2017.52                         Page 3 of 24










                                 All nucleated cells


                                                                               APC

                                                                                 MHC II
                                         MHC I
                                 CD80/86                                  CD80/86

                                   CD28       TCR                           CD28      TCR




                                                                               CD4 +
                                       CD8 +                                   T cell








                                      Proliferation,                           Proliferation,
                                     Differentiation,                         Differentiation,
                                   Cytokine secretion                        Cytokine secretion


                                     +
               Figure 1. T cell activation. CD8  T cells inspect the surface of cells they encounter and are activated if a T cell receptor binds to a
                                                                                                     +
               presented pMHC-I complex, leading to downstream processes including proliferation, differentiation, and cytokine secretion. CD4  T cells
               are similarly activated when binding pMHC-II complexes presented by professional APCs such as dendritic cells. A co-stimulating signal
               from CD28/CD80 (86) binding is required for full activation; its absence leads to T cell anergy. APC: antigen-presenting cell; MHC: major
               histocompatibility complex; TCR: T cell receptor
               brakes” on adaptive immunity, where for example cytotoxic T-lymphocyte associated protein 4 (CTLA-4)
                                                                         [11]
               competes with CD80/86 in binding CD28, thus suppressing activation .
                                                                                               [12]
               The detection limit for such T cell triggering is impressively low (four pMHC per TCR cluster) . Note that
                                     4
               the vast majority of the 10  presented peptides in vivo are in fact normal “self” peptides, with only a few from
                                  [13]
               foreign antigens, if any .
               MHC molecules and T cells come in two subtype pairs [Figure 1]. MHC class I (MHC-I) is normally
               expressed in all nucleated cells and presents intracellular (endogenous) antigen fragments. The pMHC-I
                                            +
               complexes are recognized by CD8  T cells, which are then activated and differentiate into cytotoxic T cells
               (CTLs) with direct cell killing capability. MHC class II (MHC-II) is expressed in “professional” antigen
               presenting cells (APCs), including dendritic cells, and presents exogenous antigens that have been engulfed
                                                                           +
               by the APC. The resulting pMHC-II complexes are recognized by CD4  T cells, which can differentiate e.g.
               into T helper cells whose primary role is to activate other immune system components.

               The loaded peptides in the case of MHC-I are typically 8 to 12 residues in length and are loaded into a
               groove that is closed on both ends. The MHC-II-loaded peptides range in length from 12 to 25 residues and
               are loaded into a groove that is open on both ends [Figure 2] [6,7,14] .
   17   18   19   20   21   22   23   24   25   26   27